BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19182791)

  • 1. Chfr is linked to tumour metastasis through the downregulation of HDAC1.
    Oh YM; Kwon YE; Kim JM; Bae SJ; Lee BK; Yoo SJ; Chung CH; Deshaies RJ; Seol JH
    Nat Cell Biol; 2009 Mar; 11(3):295-302. PubMed ID: 19182791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
    Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
    J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
    Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
    J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of HDAC1 via TCL1-pAKT-CHFR axis is a key element for NANOG-mediated multi-resistance and stem-like phenotype in immune-edited tumor cells.
    Woo SR; Lee HJ; Oh SJ; Kim S; Park SH; Lee J; Song KH; Kim TW
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1812-1818. PubMed ID: 30060952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.
    Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM
    Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.
    Jin L; Datta PK
    Cell Cycle; 2014; 13(24):3909-20. PubMed ID: 25483064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.
    Loring GL; Christensen KC; Gerber SA; Brenner C
    Cell Cycle; 2008 Jan; 7(1):96-105. PubMed ID: 18202552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
    Kang D; Chen J; Wong J; Fang G
    J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
    Fukuda T; Kondo Y; Nakagama H
    PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
    Jiang G; Fang H; Shang X; Chen X; Cao F
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHFR: a key checkpoint component implicated in a wide range of cancers.
    Sanbhnani S; Yeong FM
    Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions.
    Kim JM; Cho EN; Kwon YE; Bae SJ; Kim M; Seol JH
    Biochem Biophys Res Commun; 2010 May; 395(4):515-20. PubMed ID: 20388495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
    Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
    Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1.
    Luo H; Zhou Z; Huang S; Ma M; Zhao M; Tang L; Quan Y; Zeng Y; Su L; Kim J; Zhang P
    Cell Death Dis; 2021 Aug; 12(9):820. PubMed ID: 34462429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
    Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
    Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between Chfr and Kif22 controls genomic stability.
    Maddika S; Sy SM; Chen J
    J Biol Chem; 2009 May; 284(19):12998-3003. PubMed ID: 19321445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR).
    Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R
    J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
    Privette LM; González ME; Ding L; Kleer CG; Petty EM
    Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.